Authors: Holst-Hansen, C Low, JA Stephens, RW Johnson, MD Carmeliet, P Frandsen, TL Brunner, N Dickson, RB

Citation: C. Holst-hansen et al., Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat, BREAST CANC, 68(3), 2001, pp. 225-237

Authors: Bajou, K Masson, V Gerard, RD Schmitt, PM Albert, V Praus, M Lund, LR Frandsen, TL Brunner, N Dano, K Fusenig, NE Weidle, U Carmeliet, G Loskutoff, D Collen, D Carmeliet, P Foidart, JM Noel, AS

Citation: K. Bajou et al., The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies, J CELL BIOL, 152(4), 2001, pp. 777-784

Authors: Frandsen, TL Holst-Hansen, C Nielsen, BS Christensen, IJ Nyengaard, JR Carmeliet, P Brunner, N

Citation: Tl. Frandsen et al., Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model, CANCER RES, 61(2), 2001, pp. 532-537

Authors: Nielsen, BS Lund, LR Christensen, IJ Johnsen, M Usher, PA Wulf-Andersen, L Frandsen, TL Dano, K Gundersen, HJG

Citation: Bs. Nielsen et al., A precise and efficient stereological method for determining murine lung metastasis volumes, AM J PATH, 158(6), 2001, pp. 1997-2003

Authors: Lund, LR Romer, J Bugge, TH Nielsen, BS Frandsen, TL Degen, JL Stephens, RW Dano, K

Citation: Lr. Lund et al., Functional overlap between two classes of matrix-degrading proteases in wound healing, EMBO J, 18(17), 1999, pp. 4645-4656

Authors: Pedersen, AN Holst-Hansen, C Frandsen, TL Nielsen, BS Stephens, RW Brunner, N

Citation: An. Pedersen et al., The urokinase plasminogen activation system in breast cancer, CONT CANC R, 3, 1999, pp. 325-345